IPG Photonics Offers €300M for Lumibird Medical

By Ahmed Jamerson • Friday, July 17 13:04 • Permanent Link

IPG Photonics said July 16 it has made a binding offer to acquire Lumibird Medical for €300 million in cash, with up to an additional €50 million in contingent earnout payments tied to 2026 and 2027 performance metrics.

The company said the deal would add about $1 billion in addressable market for its advanced solutions business and create a larger medical laser platform spanning ophthalmology and urology. IPG said the purchase will be funded with cash on hand.

Lumibird Medical reported fiscal 2025 revenue of €112.2 million and EBITDA of €24.1 million, for an EBITDA margin of 21.5%. The company said it has more than 450 employees and operates three major global facilities.

IPG said it expects the transaction to close in the fourth quarter of 2026, after completion of the information and consultation process with Lumibird Medical’s works council and signing of a definitive purchase agreement. Today the company's shares have moved -0.58% to a price of $102.765. For the full picture, make sure to review IPG PHOTONICS CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.